Impact of reactivation on the sequelae of multi-system Langerhans cell histiocytosis patients

被引：9
|
作者：
Morimoto, Akira [1 ]
Kobayashi, Ryoji [2 ]
Maeda, Miho [3 ]
Asami, Keiko [4 ]
Bessho, Fumio [5 ]
Imashuku, Shinsaku [6 ]
机构：
[1] Kyoto Prefectural Univ Med, Dept Pediat, Grad Sch Med Sci, Kamigyo Ku, Kyoto 6028566, Japan
[2] Hokkaido Univ, Grad Sch Med, Dept Pediat, Sapporo, Hokkaido, Japan
[3] Nippon Med Coll, Dept Pediat, Tokyo 113, Japan
[4] Niigata Canc Ctr, Div Pediat, Niigata, Japan
[5] Kyorin Univ, Sch Med, Dept Pediat, Tokyo, Japan
[6] Takasago Seibu Hosp, Div Pediat, Takasago, Hyogo, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2008年 / 50卷 / 04期
关键词：
D O I：
10.1002/pbc.21315
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：931 / 932
页数：2
相关论文
共 50 条
  • [41] A rare case of mortality with multi-system Generalised Indeterminate Cell Histiocytosis
    Morgan, Emma
    Yau, Benny
    Mortimore, Rohan
    Tang, Fiona
    Robertson, Ivan
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2022, 63 : 97 - 98
  • [42] Outcome for Children with Multi-System Langerhans Cell Histiocytosis after Using a LCH II-Based Protocol in Shanghai, China
    Gao, Yi-Jin
    Wu, Fang-Fang
    Pan, Ci
    Chen, Jing
    Tang, Jing-Yan
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S20 - S20
  • [43] Paediatric Langerhans Cell Histiocytosis Disease: Long-Term Sequelae in the Hypothalamic Endocrine System
    Vaiani, Elisa
    Felizzia, Guido
    Lubieniecki, Fabiana
    Braier, Jorge
    Belgorosky, Alicia
    HORMONE RESEARCH IN PAEDIATRICS, 2021, 94 (1-2): : 9 - 17
  • [44] SPONTANEOUS REMISSION OF MULTI-SYSTEM HISTIOCYTOSIS-X
    BROADBENT, V
    DAVIES, EG
    HEAF, D
    PINCOTT, JR
    PRITCHARD, J
    LEVINSKY, RJ
    ATHERTON, DJ
    TUCKER, S
    LANCET, 1984, 1 (8371): : 253 - 254
  • [45] Pneumothorax in patients with Langerhans cell histiocytosis
    Radzikowska, Elzbieta
    Blasinska-Przerwa, Katarzyna
    Wiatr, Elzbieta
    Langfort, Renata
    Roszkowski-Sliz, Kazimierz
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [46] INDOMETHACIN AS A SINGLE AGENT OF TREATMENT OF PATIENTS WITH BONE LANGERHANS CELL HISTIOCYTOSIS AT DIAGNOSIS OR AFTER REACTIVATION
    Braier, Jorge
    Pollono, Daniel
    Rey, Guadalupe
    Lotella, Antonio
    Lagomarsino, Eduardo
    Otero, Eduardo
    Chantada, Guillermo
    Rosso, Diego
    PEDIATRIC BLOOD & CANCER, 2013, 60 (09) : E72 - E73
  • [47] Langerhans Cell Histiocytosis of the Orbit: Spectrum of Disease and Risk of Central Nervous System Sequelae in Unifocal Cases
    Esmaili, Neda
    Harris, Gerald J.
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2016, 32 (01): : 28 - 34
  • [48] Acute-phase ITIH4 levels distinguish multi-system from single-system Langerhans cell histiocytosis via plasma peptidomics
    Murakami, Ichiro
    Oh, Yukiko
    Morimoto, Akira
    Sano, Hitoshi
    Kanzaki, Susumu
    Matsushita, Michiko
    Iwasaki, Takeshi
    Kuwamoto, Satoshi
    Kato, Masako
    Nagata, Keiko
    Hayashi, Kazuhiko
    Imashuku, Shinsaku
    Gogusev, Jean
    Jaubert, Francis
    Oka, Takashi
    Yoshino, Tadashi
    CLINICAL PROTEOMICS, 2015, 12
  • [49] Acute-phase ITIH4 levels distinguish multi-system from single-system Langerhans cell histiocytosis via plasma peptidomics
    Ichiro Murakami
    Yukiko Oh
    Akira Morimoto
    Hitoshi Sano
    Susumu Kanzaki
    Michiko Matsushita
    Takeshi Iwasaki
    Satoshi Kuwamoto
    Masako Kato
    Keiko Nagata
    Kazuhiko Hayashi
    Shinsaku Imashuku
    Jean Gogusev
    Francis Jaubert
    Takashi Oka
    Tadashi Yoshino
    Clinical Proteomics, 2015, 12
  • [50] Long term sequelae and quality of life after multisystem Langerhans cell histiocytosis
    Nanduri, Vasanta
    Levitt, Gill
    Glaser, Adam
    Stanhope, Richard
    Pritchards, Jon
    PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 554 - 554
12345